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A biosensor can be defined as a compact analytical device incorporating a biological or 
biologically-derived sensing element either integrated within or intimately associated with a 
physicochemical transducer. The aim of a biosensor is to produce discrete or continuous digital 
electronic signals which are proportional to a single analyte or a related group of analytes. The 
biological element is capable of sensing the presence, activity or concentration of a substance in 
solution. These interactions produce a measurable change in a solution property, which the 
transducer converts into a quantifiable electrical signal. Therefore, biosensor is a general term 
for a wide range of devices that measure the presence or concentration of biological or chemical 
molecules by translating a biomolecular interaction at the probe surface into a quantifiable 
physical signal. 
The development of biosensor devices has been a very active research field both in 
academic and in industrial laboratories during the last decades. This technology could be a 
serious alternative to conventional assay techniques because they can avoid expensive, complex 
and time-consuming procedures. A large number of applications for these devices range from 
clinical diagnostics, drugs research at pharmaceutical industry, online screening of water quality 
for both household and industrial use, control of industrial processes, veterinary field, food 
industry or environmental monitoring, among others. Ideally, for all these applications, it will be 
desirable to have a compact sensor with response time as low as possible, allowing real-time 
measurement and with a high sensitivity. The most widely used and well-known biosensor is the 
glucose one, which is used diary by thousands of people all around the world. 
 
There are two important steps in the development of any biosensor device: 
 
(i) The design and fabrication of a high sensitive physical transducer, that is, a device 
capable of transform efficiently the biomolecular reaction in a measurable signal.  
(ii) The stable and reliable biofunctionalization of the physical transducer with the 
appropriate selective biological receptor (proteins, DNA, cells, aptamers,…) 
 
 
(i) Physical transducers 
There are several physical methods to obtain a transducing signal like those based on 
amperometric, potentiometric or acoustic systems. However, transducers that make use of 
optical principles offer more attractive characteristics such as the immunity to electromagnetic 
interference, the use in aggressive environments and, in general, a higher sensitivity. Generally, 
in optical transducers, the chemical or biological stimulus produces changes in the 
characteristics of the medium in contact with the light path, like a variation in its emission 
properties (luminescence), in the absorption coefficients or in the refractive index. This 
variation will induce a change in the propagation properties of light (wavelength, intensity, 
polarisation, phase velocity). Several techniques have been proposed to measure the induced 
change in the propagation properties of light. One of the most successful label-free and 
commercially accepted optical biosensors is the Surface Plasmon Resonance (SPR) sensor. This 
biosensor is widely employed for determination of many types of interactions and hundreds of 
publications appear in the literature every year. The detection limit of actual SPR devices is 
below 1 pg.mm-2. Other optical biosensors make use of optical waveguides as the basic element 
of their structure for light propagation and are based on the evanescent field sensing. For 
example, the interferometer device (as Mach-Zehnder or the Young interferometer) based on 
waveguides is able to achieve impressive sensitivity levels in a label-free and real-time scheme 
in the range of 0.1 pg/mm2
 
(picomolar concentration) which means a detection limit of 10-8
 
in 
refractive index.  
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Fig.1 Schemes and photographs of some nanodevices which has been proposed for biosensing. 
 
In recent years several interesting nano-developments (see Fig. 1) have been proposed 
as highly sensitive transducers for biosensing (as metal or magnetic nanoparticles, quantum 
dots, carbon nanotubes, photonic crystals, ring resonators, nanocatilevers, etc.,). Although all of 
these developments are interesting from a scientific point of view, the real implementation of 
much of them is still hampered by several factors. First, most of them still require the use of 
labels to readout the biomolecular interaction, which are undesirable for real applications (direct 
reading is much more precise). Second, the path to connect such nano-developments to the 
operation in a real world environment has not been paved and large and complicated laboratory 
setups are needed for signal acquisition and processing. 
In contrast, micro/nanobiosensor devices based on microelectronics and related 
(BIO)MEMS/NEMS technologies could provide a technological solution for achieving label-
free devices which could be operated in a stand-alone fashion outside a laboratory environment. 
This fabrication approach allows the flexible development of miniaturized compact sensing 
devices, microfluidics delivery systems and the possibility of fabricating multiple sensors on 
one chip, opening the way for high-throughput screening (see Fig. 2). Additional advantages are 
the robustness, reliability, potential for mass production with consequent reduction of 
production costs, low energy consumption and simplicity in the alignment of the individual 
elements. 
 
 
 
Fig. 2. Nanomechanical biosensors employed for clinical diagnosis 
 (ii) Biofunctonalization 
The immobilisation of the receptor molecule on the sensor surface is a key point for the 
performance of the sensor. A selective biological coating (receptor) must be immobilized onto 
the sensing areas in order to make a highly selective surface. The chosen immobilisation 
method must retain the stability and activity of the bound biological receptor. The 
immobilisation methods available are divided in two general categories: (i) covalent coupling 
and (ii) affinity non-covalent interactions.  
In the affinity bonding, a high affinity-capture ligand is non-reversible immobilised on the 
sensor surface: for example, streptavidin monolayers using biotinylated biomolecules for 
recognition. Another approach is to form a Self-Assembled Monolayers (SAM) of alkylsilanes 
and then the receptor can be coupled using the end of the SAM via a functional group (-NH2, -
COOH,...). The affinity binding can be performed with biotin conjugated ligands to avidin, 
streptavidin or neutravidin modified surfaces. The advantage of this procedure is an oriented 
binding ensuring equal binding sites. The functionalisation of the transducer also depends on the 
surface. Transducers with gold are usually modified with thiols, forming self-assembled 
monolayers. Oxidise surfaces can easily be modified with silane chemistry.  
 
The Course will start with a basic introduction to biosensors, and will follow with a deep 
overview of the different physical transducer, with special emphasis in photonics and 
nanotechnology transducers. During the course, the design, fabrication, characterization, and 
testing of biosensor devices will be reviewed. In addition, the biofunctionalization techniques 
for biological receptor inclusion will be studied as well. Further integration of biosensors, 
microfluidics, and electronic functions on a single sensing circuit could lead to a complete ‘‘lab-
on-achip’’ technological solution which could be used for performing in situ analysis. The way 
of the integration in ‘‘lab-on-a-chip’’ Microsystems will be also reviewed.  
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